Efficacy and Safety of select Flavonoids for the Treatment of Uncomplicated SARS-CoV-2 COVID-19
Phase 2
- Conditions
- Respiratory
- Registration Number
- PACTR202010537777617
- Lead Sponsor
- EMSKE Phytochem
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients 18-80 y.o.presenting with positive PCR test for COVID-19.
Exclusion Criteria
Patients on chronic medications that require P450 enzyme to be uninhibited. (example - atorvastatin, blood thinners, heart arrhythmia medication)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method